October 5, 2020: "Novartis announced that results of two new post-hoc analyses of the Phase III HAWK and HARRIER clinical trials in wet age-related macular...
October 2020: "The Phase I/II clinical trial for the COVID-19 vaccine AZD1222 has resumed in Japan after discussion with the Japanese Pharmaceuticals and Medical...
Specially designed Course for Freshers and entry Level Professionals on Pharmacovigilance is going to be held On 10 Oct (Saturday): 04:00-06:00pm and 11 Oct...
Sept. 29, 2020: "Eton Pharmaceuticals, a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rare pediatric diseases, today announced that the U.S....
29 September 2020: "Novacy, an international specialist in clinical diagnostics, announces it has signed a new supply contract with the UK Department of Health...
September 28, 2020: "The U.S. FDA issued the final guidance, “Breast Implants - Certain Labeling Recommendations to Improve Patient Communication,” as part of the...
September 28, 2020 : A set of agreements to make available, for low and middle-income countries, affordable, high-quality COVID-19 antigen rapid tests were announced by...
September 28, 2020: "ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders announced the...
September 28, 2020: "The ABPI and EFPIA have both emphasised the need for trade talks to mitigate medicine supply chain disruptions following Brexit.
The Association...
"Medical coding is the transformation into necessary medical alphanumeric codes of healthcare diagnoses, treatments, medical facilities, and supplies.
The diagnosis and codes of procedure are...
September 2020: "Oncimmune Holdings, the leading global immunodiagnostics group, has announced that it has signed a collaboration with Genentech, a member of the Roche...
September 25, 2020: US-based biotechnology firm Novavax has started the first Phase III clinical trial of its potential Covid-19 vaccine, NVX-CoV2373, in the UK.
US-based...